5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Heart Failure and Transplant Cardiology
Heart failure and transplant cardiology represent critical areas in the management of advanced cardiovascular disease. Heart failure occurs when the heart is unable to pump sufficient blood to meet the body's needs, leading to symptoms such as shortness of breath, fatigue, and fluid retention. For patients with severe, refractory heart failure, heart transplantation offers a life-saving solution. The field of transplant cardiology involves the evaluation, management, and post-operative care of heart transplant recipients. With advances in immunosuppressive therapy and rejection monitoring, transplant cardiology has improved outcomes, though it still faces challenges such as organ shortage and long-term graft survival. Ongoing research in regenerative medicine and mechanical circulatory support systems continues to enhance the management of heart failure and expand options for patients awaiting transplants.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain